AHA comments on provisions in House Democrats’ COVID-19 relief bill

May 14, 2020 - 03:49 PM
COVID19 Web Sized

The AHA today provided comments on a number of provisions affecting hospitals and health systems that were included in the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act — a $3 trillion COVID-19 relief package that was unveiled Tuesday by House Democratic leaders.
 
Among other areas that AHA commented on were provisions related to: funding available to providers through the Public Health and Social Services Emergency Fund and establishing a new distribution methodology; modifying the terms of the accelerated and advanced payments available through the Medicare program; changes to Medicaid and health care coverage; public health provisions and COVID-19 testing; occupational safety standards; liability protection for health care; and the Paycheck Protection Program. 

View the letter to see the detailed comments on these and other provisions in the bill.
 
AHA members May 12 received a Special Bulletin with highlights of provisions included in the bill that are important to hospitals and health systems. The House is expected to vote on the bill tomorrow. The Senate is not expected to take up the bill in its current form.

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…